BIOS Frontier Science: Exploring Emerging Modalities Guided By TechBio’s Top Researchers 🔬
BIOS Frontier Science: Exploring Emerging Modalities Alongside TechBio’s Top Researchers 🔬
BIOS: Nucleus of Life Science Innovation 🚀
JOBS
BIOS Talent: Find Jobs @ Breakout TechBio Startups — Search Jobs 🚀
Post Jobs: Add Your Startup to BIOS Talent — Post Now 🎉
Students: Join Alix Ventures Fellowship — Join Now 🧬
BIOS Contributor: Share Your Thought Leadership — Join Now🔬
CONTENT & COMMUNITY
BIOS Daily: Join 25K+ Subscribers Following TechBio — Sign Up 🔥
BIOS Insider: Premium TechBio Thought Leadership — Sign Up ✨
BIOS Commons: World’s Largest #TechBio Community — Join Now 🎉
INVEST
BIOS Angels: 1st TechBio Angel Investing Syndicate — Join Now 🌟
Alix Limited: Invest in Breakout TechBio Startups — Learn More 🧠
By:
Alix Ventures: Supporting Early Stage Life Science Startups Engineering Biology to Drive Radical Advances in Human Health
Calling All Innovators — Click to Reach Out 🚀
Overview
We’re excited to announce the launch of BIOS Frontier Science — A new YouTube series focused on exploring emerging modalities featuring the world’s leading researchers on the cutting edge of life saving innovations🔬
As we embark on the century of biology, the era of platform companies is just beginning. The Life Science sector with the rise of TechBio (Melding of technology & biology) is experiencing unprecedented innovation, a change we believe is leading to some of the most impactful solutions in decades.
On this show, we will interview professors from leading research universities and discuss ongoing projects in their labs that are pushing the bounds of life sciences. Each episode will feature a professor explaining the science behind their most recent discoveries, the potential implications for their work, how it could be commercialized, and the most pressing challenges / next steps for the field.
This is an amazing opportunity for investors, researchers, entrepreneurs, & Pharma to keep tabs on some of the most interesting and bleeding edge biological discoveries.
Guests on the Show 🌟
The stars of the show & our guides into the great beyond are leading professors in their respective fields from top leading research universities around the world, such as: MIT, Stanford, CalTech, Berkeley, Harvard, UCSF, & so many more.
Topics We’ll Explore 🔬
We will explore a wide range of topics from emerging therapeutic modalities to new approaches for diagnostics to novel techniques enhancing R&D.
We’ll dive deep on bleeding edge early-stage technologies with significant potential solve unmet needs & disrupt Life Sciences industry as we now it. For most episodes, the featured technologies will either still be in academic labs or have been recently spun out into new companies — Our goal is to make you aware of these advances long before they become mainstream knowledge & household names.
Some spaces we are excited to cover…
DNA Origami
RNAi
Condensates
Organoids
Enzymatic DNA Production
Retrons & Borgs
Amongst Others
Checkout Our Episodes…
Jeff Karp is the Distinguished Chair in Clinical Anesthesiology, Perioperative and Pain Medicine at Brigham & Women’s Hospital and Professor of Anesthesia at Harvard Medical School in Boston. He is also a principal faculty member at the Harvard Stem Cell Institute, and an affiliate faculty member at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology.
He works in the fields of drug delivery, medical devices, stem cell therapeutics, and tissue adhesives. He has published over 125 peer-reviewed papers, with 24,000 citations, and has given over 300 invited lectures. He has over 100 issued or pending national and international patents. Several technologies developed in his lab have led to multiple products currently in development or on the market and for the launch of ten companies that have raised over $450 million in funding. Technologies include high-tech skincare (Skintifique, products sold in pharmacies throughout EU), tissue adhesives (Tissium, EU Approval in 2017) and 3D printed biomedical devices, immunomodulation with biologically responsive materials (Alivio Tx), small molecule regenerative therapeutics ($FREQ — NASDAQ), cannabinoid therapeutics (Molecular Infusions acquired by Suterra Wellness in 2019), biomedical devices to improve child safety (Landsdowne Labs), needles that automatically stop at their target (Bullseye Therapeutics), a bioengineered luminal coating for controlled GI targeting (Altrix Bio), and a fun hand soap to encourage children to wash their hands (One Fun Company).
Learn More @ https://www.karplab.net/team/jeff-karp
📣 If you enjoyed this post please clap 👏 & comment 💬 to let us know
Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement or recommendation by Alix Ventures, BIOS Community, or its affiliates. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by Alix Ventures employees are those of the employees and do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, and content sponsors.
Join BIOS Community 🎉
Become a member, continue the conversation, connect with like-minded Life Science innovators, access exclusive resources, & invite-only events…
Apply to Join — Membership Application
For More Interesting Content 💭
🧬 Podcast — Stream Full Episodes
🧪 YouTube — Watch Videos
🩺 Twitter — Explore Feed
🦠 LinkedIn — Read Posts